Work

CVN058, a 5-HT3 Receptor Antagonist, Shows Acute, Dose Dependent Improvement of Mismatch Negativity in a Double-Blind, Placebo-Controlled, Single Dose Cross-Over Study in Schizophrenia and Schizoaffective Disorder

Year: 2021

Type: article

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2021.02.086

Authors: Pejman Sehatpour, Heloise De Baun, Daniel Javitt, David Margolin, Nicola Brice, Mark Carlton, Lee Dawson, Roland Burli, Marlene Carlson, Joshua Kantrowitz

Institutions: Columbia University, New York State Psychiatric Institute

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3165938756

FWCI:

Cites:

Cited by:

Related to: 10